Back to Los Angeles Capital Management LLC Los Angeles Capital Management LLC

TGTXTGTX

Showing 8 of 23 quarters

Position history for Los Angeles Capital Management LLCLos Angeles Capital Management LLC's holdings in TG Therapeutics, Inc.

Yes. Los Angeles Capital Management holds 10,728 shares of TGTX (TG Therapeutics), worth $589,396, as of its Q2 2026 13F filing. It reduced the position by 13,643 shares (-56.0%) from Q1 2026. Los Angeles Capital Management has held TGTX since Q1 2022, across 18 quarterly 13F filings.

Current Value

$589,396

Current Shares

10,728

Total Value Change

-$2.3M

Total Shares Change

-112,673

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
10,728
-56.0%
$589,3960.0%$54.94
0
2026-Q1
Increased
24,371
+42.8%
$809,6060.0%$33.22
33
2025-Q4
Unchanged
17,070
0.0%
$580,7220.0%$29.81
0
2025-Q3
Increased
17,070
+12.9%
$616,6540.0%$36.13
28
2025-Q2
Increased
15,114
+75.4%
$543,9530.0%$35.99
37
2025-Q1
Decreased
8,617
-88.2%
$339,7680.0%$39.43
0
2024-Q4
Decreased
73,117
-40.8%
$2.2M0.0%$30.10
0
2024-Q3
Increased
123,401
+33.7%
$2.9M0.0%$23.39
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used